Central nervous system T-cell lymphoma in acquired immunodeficiency syndrome.
Yotsumoto
Mihoko
M
Funato
Kotaro
K
Hashimoto
Yuko
Y
Fujimoto
Hiroaki
H
Fukutake
Katsuyuki
K
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001921:Brain / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use; D000068898:Raltegravir Potassium; D018119:Stavudine / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011760:Pyrrolidinones; D019259:Lamivudine; D000068898:Raltegravir Potassium; D018119:Stavudine; D008727:Methotrexate